RAVEN Biotechnologies' Acquisition

RAVEN Biotechnologies was acquired by MacroGenics on July 22, 2008.

Raven biotechnologies is a privately held biotechnology company focused on the simultaneous discovery of novel cell surface drug targets and the antibody therapeutics to regulate them. Raven's integra…

Articles about RAVEN Biotechnologies' Acquisition: